Evaluation of the Cone Outer Segment Tips Line After Epiretinal Membrane Surgery
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01549249 |
Recruitment Status :
Completed
First Posted : March 9, 2012
Last Update Posted : November 14, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Epiretinal Membrane | Device: optical coherence tomography | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 333 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | Single (Investigator) |
Primary Purpose: | Treatment |
Official Title: | Evaluation of the Cone Outer Segment Tips Line After Epiretinal Membrane Surgery |
Study Start Date : | June 2008 |
Actual Primary Completion Date : | November 2010 |
Actual Study Completion Date : | November 2011 |
Arm | Intervention/treatment |
---|---|
No Intervention: vitrectomy |
Device: optical coherence tomography
spectral-domain optical coherence tomography
Other Name: vitreous surgery |
- best-corrected visual acuity [ Time Frame: one year ]
- Integrity and defect length of the photoreceptor layer detected by spectral-domain optical coherence tomography [ Time Frame: one year ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 40 Years to 90 Years (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients who received epiretinal membrane surgery between June, 2008, and November, 2010, at Kyorin Eye Center.
- Only eyes with postoperative follow-up period more than 6 months were included.
Exclusion Criteria:
- Eyes with secondary epiretinal membrane (previous history of uveitis, intraocular surgery, pre-operatively noted retinal breaks, etc.) were excluded.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01549249
Japan | |
Kyorin Eye Center | |
Mitaka, Tokyo, Japan, 181-8611 |
Principal Investigator: | Makoto Inoue, MD | Kyorin Eye Center |
Responsible Party: | Makoto Inoue, Associate professor, Kyorin University |
ClinicalTrials.gov Identifier: | NCT01549249 |
Other Study ID Numbers: |
KyorinEye007 |
First Posted: | March 9, 2012 Key Record Dates |
Last Update Posted: | November 14, 2012 |
Last Verified: | November 2012 |
cone outer segment tips line inner segment/outer segment junction line optical coherence tomography epiretinal membrane |
Epiretinal Membrane Retinal Diseases Eye Diseases |